149 related articles for article (PubMed ID: 15087409)
1. Using gene expression profiling to differentiate benign versus malignant thyroid tumors.
Mazzanti C; Zeiger MA; Costouros NG; Umbricht C; Westra WH; Smith D; Somervell H; Bevilacqua G; Alexander HR; Libutti SK
Cancer Res; 2004 Apr; 64(8):2898-903. PubMed ID: 15087409
[TBL] [Abstract][Full Text] [Related]
2. Identification of genes differentially expressed in benign versus malignant thyroid tumors.
Prasad NB; Somervell H; Tufano RP; Dackiw AP; Marohn MR; Califano JA; Wang Y; Westra WH; Clark DP; Umbricht CB; Libutti SK; Zeiger MA
Clin Cancer Res; 2008 Jun; 14(11):3327-37. PubMed ID: 18519760
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of genetic biomarkers for distinguishing benign from malignant thyroid neoplasms.
Nagar S; Ahmed S; Peeples C; Urban N; Boura J; Thibodeau B; Akervall J; Wilson G; Long G; Czako P
Am J Surg; 2014 Apr; 207(4):596-601. PubMed ID: 24713092
[TBL] [Abstract][Full Text] [Related]
4. The combination of four molecular markers improves thyroid cancer cytologic diagnosis and patient management.
Panebianco F; Mazzanti C; Tomei S; Aretini P; Franceschi S; Lessi F; Di Coscio G; Bevilacqua G; Marchetti I
BMC Cancer; 2015 Nov; 15():918. PubMed ID: 26581891
[TBL] [Abstract][Full Text] [Related]
5. Implications of a suspicious afirma test result in thyroid fine-needle aspiration cytology: an institutional experience.
Lastra RR; Pramick MR; Crammer CJ; LiVolsi VA; Baloch ZW
Cancer Cytopathol; 2014 Oct; 122(10):737-44. PubMed ID: 25123499
[TBL] [Abstract][Full Text] [Related]
6. Gene profiling identifies genes specific for well-differentiated epithelial thyroid tumors.
Puskas LG; Juhasz F; Zarva A; Hackler L; Farid NR
Cell Mol Biol (Noisy-le-grand); 2005 Sep; 51(2):177-86. PubMed ID: 16171553
[TBL] [Abstract][Full Text] [Related]
7. Discrimination of benign and malignant thyroid nodules by molecular profiling.
Finley DJ; Zhu B; Barden CB; Fahey TJ
Ann Surg; 2004 Sep; 240(3):425-36; discussion 436-7. PubMed ID: 15319714
[TBL] [Abstract][Full Text] [Related]
8. Classification of follicular thyroid tumors by molecular signature: results of gene profiling.
Barden CB; Shister KW; Zhu B; Guiter G; Greenblatt DY; Zeiger MA; Fahey TJ
Clin Cancer Res; 2003 May; 9(5):1792-800. PubMed ID: 12738736
[TBL] [Abstract][Full Text] [Related]
9. ECM1 and TMPRSS4 are diagnostic markers of malignant thyroid neoplasms and improve the accuracy of fine needle aspiration biopsy.
Kebebew E; Peng M; Reiff E; Duh QY; Clark OH; McMillan A
Ann Surg; 2005 Sep; 242(3):353-61; discussion 361-3. PubMed ID: 16135921
[TBL] [Abstract][Full Text] [Related]
10. Molecular markers for discrimination of benign and malignant follicular thyroid tumors.
Fryknäs M; Wickenberg-Bolin U; Göransson H; Gustafsson MG; Foukakis T; Lee JJ; Landegren U; Höög A; Larsson C; Grimelius L; Wallin G; Pettersson U; Isaksson A
Tumour Biol; 2006; 27(4):211-20. PubMed ID: 16675914
[TBL] [Abstract][Full Text] [Related]
11. A morpho-molecular diagnosis of papillary thyroid carcinoma: BRAF V600E detection as an important tool in preoperative evaluation of fine-needle aspirates.
Marchetti I; Lessi F; Mazzanti CM; Bertacca G; Elisei R; Coscio GD; Pinchera A; Bevilacqua G
Thyroid; 2009 Aug; 19(8):837-42. PubMed ID: 19534623
[TBL] [Abstract][Full Text] [Related]
12. DNA Methylation-Based Method to Differentiate Malignant from Benign Thyroid Lesions.
Barros-Filho MC; Dos Reis MB; Beltrami CM; de Mello JBH; Marchi FA; Kuasne H; Drigo SA; de Andrade VP; Saieg MA; Pinto CAL; Kowalski LP; Rogatto SR
Thyroid; 2019 Sep; 29(9):1244-1254. PubMed ID: 31328658
[No Abstract] [Full Text] [Related]
13. An independent study of a gene expression classifier (Afirma) in the evaluation of cytologically indeterminate thyroid nodules.
McIver B; Castro MR; Morris JC; Bernet V; Smallridge R; Henry M; Kosok L; Reddi H
J Clin Endocrinol Metab; 2014 Nov; 99(11):4069-77. PubMed ID: 24780044
[TBL] [Abstract][Full Text] [Related]
14. Performance of the Afirma Gene Expression Classifier in Hürthle Cell Thyroid Nodules Differs from Other Indeterminate Thyroid Nodules.
Brauner E; Holmes BJ; Krane JF; Nishino M; Zurakowski D; Hennessey JV; Faquin WC; Parangi S
Thyroid; 2015 Jul; 25(7):789-96. PubMed ID: 25962906
[TBL] [Abstract][Full Text] [Related]
15. Digital gene expression profiling of a series of cytologically indeterminate thyroid nodules.
Giannini R; Torregrossa L; Gottardi S; Fregoli L; Borrelli N; Savino M; Macerola E; Vitti P; Miccoli P; Basolo F
Cancer Cytopathol; 2015 Aug; 123(8):461-70. PubMed ID: 26033834
[TBL] [Abstract][Full Text] [Related]
16. Molecular profiling distinguishes papillary carcinoma from benign thyroid nodules.
Finley DJ; Arora N; Zhu B; Gallagher L; Fahey TJ
J Clin Endocrinol Metab; 2004 Jul; 89(7):3214-23. PubMed ID: 15240595
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic and extent of disease multigene assay for malignant thyroid neoplasms.
Kebebew E; Peng M; Reiff E; McMillan A
Cancer; 2006 Jun; 106(12):2592-7. PubMed ID: 16688775
[TBL] [Abstract][Full Text] [Related]
18. A six-gene model for differentiating benign from malignant thyroid tumors on the basis of gene expression.
Rosen J; He M; Umbricht C; Alexander HR; Dackiw AP; Zeiger MA; Libutti SK
Surgery; 2005 Dec; 138(6):1050-6; discussion 1056-7. PubMed ID: 16360390
[TBL] [Abstract][Full Text] [Related]
19. Advancing the molecular diagnosis of thyroid nodules: defining benign lesions by molecular profiling.
Finley DJ; Lubitz CC; Wei C; Zhu B; Fahey TJ
Thyroid; 2005 Jun; 15(6):562-8. PubMed ID: 16029122
[TBL] [Abstract][Full Text] [Related]
20. Differentiation of human follicular thyroid adenomas from carcinomas by gene expression profiling.
Zhao J; Leonard C; Gemsenjäger E; Heitz PU; Moch H; Odermatt B
Oncol Rep; 2008 Feb; 19(2):329-37. PubMed ID: 18202778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
